The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

That’s thanks to a major philanthropic commitment from Sarasota’s Brian and Sheila Jellison Family Foundation. As the first ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

This guest essay reflects the views of Dr. Richard Barakat, physician-in-chief at the Northwell Health Cancer Institute.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Scientists are encouraged by findings that jab can eliminate tumour in patients with stage three or four kidney cancer ...

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

While January is Cervical Cancer Awareness Month, health experts say getting screened when necessary is important year-round.

Cervical cancer continues to be one of the leading causes of cancer-related deaths among women, and the Caribbean region has ...